Participate in a Study

register_now_copy

Current Studies

Cardiac Trials

Study – EX4758

  • eGFR ≥15 and < 60 mL/min/1.73 m2
  • Serum hs-CRP ≥2 mg/L at screening
  • Evidence of ASCVD by one or more of the following within the last 5 years from screening:
    • Coronary heart disease defined as at least one of the following:
    • Cerebrovascular disease defined as at least one of the following:
    • Symptomatic peripheral artery disease (PAD) defined as at least one of the following:

Type 2 Diabetes Trials:

Study – CIP341

  • Is age 18 - 80 years at time of screening.
  • Has a clinical diagnosis of type 2 diabetes for 2 years or more.
  • Is on multiple daily injection (MDI) regimen (basal/bolus regimen with longacting insulin and rapid-acting analogs), defined as greater than or equal to 2 injections per day for at least 3 months.
  • Is willing to perform fingerstick blood glucose measurements as needed.
  • Is willing to wear the system continuously throughout the study.
  • Has a Glycosylated hemoglobin (HbA1c) of less than 10% (as processed by Central Lab) at time of screening visit.
  • Is willing to upload data from the study pump, must have Internet access, and a computer system, or compatible smartphone that meets the requirements for uploading the study pump.

Type 1 or 2 Diabetes Trials:

Study – CIP322

  • Individual is 2-75 years of age at time of enrollment.
  • Subject has a clinical diagnosis of type 1 or type 2 diabetes for a minimum of 6 months duration as determined via medical record/ source documentation by an individual qualified to make a medical diagnosis.
  • Subject is using insulin to treat their diabetes.
  • Subject agrees to comply with the study protocol requirements.
  • Subject is willing to perform SMBG approximately every 15 minutes /20 minutes during FST.
  • If subject is participating in YSI FST, subject has adequate venous access as assessed by investigator or appropriate staff.
 
Endocrine Research Solutions, Inc.
1475 Holcomb Bridge Road, Suite 129, Roswell, GA 30076
Ph: 678.878.4750 Fx: 678.878.4751